Cognition Disorders  >>  memantine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
memantine / Generic mfg.
Memantine-MS, NCT00638833 / 2006-003887-76: Memantine Therapy for Multiple Sclerosis

Terminated
2
20
Europe
Memantine, Ebixa, Placebo
Clinica Universidad de Navarra, Universidad de Navarra, H. Lundbeck A/S
Multiple Sclerosis
03/08
03/08
NCT01261741 / 2010-020737-50: Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems

Completed
2
299
Europe
Memantine, Placebo
Merz Pharmaceuticals GmbH
Memory Disorder, Retention Disorder, Cognitive, Subjective Cognitive Impairment, Memory, Concentration or Attention Problems
08/11
09/11

Download Options